BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2466917)

  • 21. Successful closure of intestinal fistulae in an infant using the somatostatin analogue SMS 201-995.
    Wallace AM; Newman K
    J Pediatr Surg; 1991 Sep; 26(9):1097-100. PubMed ID: 1941488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial.
    Yeo CJ; Cameron JL; Lillemoe KD; Sauter PK; Coleman J; Sohn TA; Campbell KA; Choti MA
    Ann Surg; 2000 Sep; 232(3):419-29. PubMed ID: 10973392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula.
    Sancho JJ; di Costanzo J; Nubiola P; Larrad A; Beguiristain A; Roqueta F; Franch G; Oliva A; Gubern JM; Sitges-Serra A
    Br J Surg; 1995 May; 82(5):638-41. PubMed ID: 7613936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of somatostatin analogue for intestinal and pancreatic fistulas].
    Paran H; Neufeld D; Epstein T; Bendahan J; Freund U
    Harefuah; 1991 Feb; 120(4):185-6. PubMed ID: 2066018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Octreotide administration in the treatment of pancreatic fistulae after pancreas transplantation.
    Secchi A; Di Carlo V; Martinenghi S; La Rocca E; Caldara R; Staudacher C; Ferrari G; Castoldi R; Torri G; Pozza G
    Transpl Int; 1992 Sep; 5(4):201-4. PubMed ID: 1418310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors of pancreatic leakage after pancreaticoduodenectomy.
    Yang YM; Tian XD; Zhuang Y; Wang WM; Wan YL; Huang YT
    World J Gastroenterol; 2005 Apr; 11(16):2456-61. PubMed ID: 15832417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-arterial bolus octreotide administration during Whipple procedure in patients with fragile pancreas: a novel technique for safer pancreaticojejunostomy.
    Konstadoulakis MM; Filippakis GM; Lagoudianakis E; Antonakis PT; Dervenis C; Bramis J
    J Surg Oncol; 2005 Mar; 89(4):268-72. PubMed ID: 15726611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reappraisal of pancreaticojejunostomy after pancreaticoduodenectomy: a report of 86 cases with particular reference to the rate of pancreatic fistulation.
    Berdah S; Panis Y; Gleizes V; Sastre B; Valleur P
    Eur J Surg; 1997 May; 163(5):365-9. PubMed ID: 9195170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of exocrine pancreatic function by somatostatin?].
    Jung D; Düben W; Lux M; Heymann H
    Z Gastroenterol; 1986 Mar; 24(3):161-2. PubMed ID: 2871669
    [No Abstract]   [Full Text] [Related]  

  • 30. [Closure of postoperative anastomotic fistulas with a somatostatin analogue].
    Niv Y; Hadari A; Asaf V; Oren M
    Harefuah; 1991 Jun; 120(11):647-8. PubMed ID: 1937211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of somatostatins in the preventin of pancreatic fistulae and the treatment of digestive fistulae].
    Sales JP; Gayral F
    Ann Chir; 2000 Dec; 125(10):929-35. PubMed ID: 11195921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors of pancreatic fistula following pancreaticoduodenectomy for periampullary cancer.
    Popiela T; Kedra B; Sierzega M; Gurda A
    Hepatogastroenterology; 2004; 51(59):1484-8. PubMed ID: 15362783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Internal pancreatic fistulae with serous effusions in chronic pancreatitis.
    Dhar P; Tomey S; Jain P; Azfar M; Sachdev A; Chaudhary A
    Aust N Z J Surg; 1996 Sep; 66(9):608-11. PubMed ID: 8859161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total pancreatectomy and islet auto-transplantation as treatment for ampullary adenocarcinoma in the setting of pancreatic ductal disruption secondary to acute necrotizing pancreatitis. A case report.
    Iyegha UP; Asghar JA; Beilman GJ
    JOP; 2012 Mar; 13(2):239-42. PubMed ID: 22406611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The somatostatin analog SMA (201-995) as adjuvant treatment in patients with external fistulae of the digestive system].
    Castañón González JA; Miranda Ruíz R; Arías E; Fuentes Pintado E; Zárate Treviño A
    Gac Med Mex; 1992; 128(3):285-8. PubMed ID: 1302733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pancreaticogastrostomy in duodenocephalopancreatectomy. Operative technical note].
    Olivero S; Ibba F; Foco A; Viglione GC; Sanfelici G; Serenthà U; Sigaudo G; Remonda G
    Minerva Chir; 1979 Sep; 34(18):1185-92. PubMed ID: 548821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anastomosis or closure of the pancreatic stump after duodenopancreatectomy?].
    Marchesi M; Biffoni M; Tartaglia F; Nobili-Benedetti R; Orlando M; Lentini A; Stocco F; Campana FP
    G Chir; 1991 Mar; 12(3):121-3. PubMed ID: 1873147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
    Martineau P; Shwed JA; Denis R
    Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the effects of two somatostatin analogues in a patient with an external pancreatic fistula.
    Heij HA; Bruining HA; Verschoor L
    Pancreas; 1986; 1(2):188-90. PubMed ID: 2883648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of external pancreatic fistulas with somatostatin. Second place winner: Conrad Jobst award.
    Lansden FT; Adams DB; Anderson MC
    Am Surg; 1989 Dec; 55(12):695-8. PubMed ID: 2574557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.